Procurement
Expert Panel
Create New Account
Login
logo
Report store
Insights
Survey
Consulting
Book discovery call
logo

Blood Screening Market: Current Analysis and Forecast (2021-2027)

Region:Global

Product Code:UMHE21515

Download Sample Report
Published On

November 2021

Total pages

346

About the Report

The Blood Screening Market is estimated to grow at a CAGR of 10% during the forecasted period. Blood screening is one of the most ideal and preferred tests for diagnosing various infectious diseases. Blood screening enables physicians to diagnose diseases effectively, which helps in administering suitable treatments and monitoring the patient to avoid the spread of the disease.

Factors such as the rise in blood donations and blood transfusion-related screenings, increasing prevalence of infectious diseases, growing geriatric population, and increasing awareness about transfusion-transmitted diseases are driving the growth of this market. Untapped emerging markets such as India and China and advancements in technology hold great opportunities for this market to grow during the forecast period.

Based on product, the market is segmented into Reagents & Kits, Instruments, Software & Services. The reagents & kits segment commanded the largest share of the blood screening market in 2020. Reagents being a recurrent expense, are extensively used for immunoassays and molecular tests. Factors such as increasing blood donations and transfusion-related screenings and the increasing prevalence of infectious diseases are driving the growth of this segment.

Based on Technology, the market is segmented into Nucleic Acid Amplification (NAAT), Enzyme Linked Immunosorbent Assay (ELISA), Rapid Tests, Western Blotting, Next Generation Sequencing (NGS). Nucleic Acid Amplification (NAAT) segment commanded the largest share of the blood screening market in 2020. The largest share is attributed to the superior benefits of the technology, such as high sensitivity and specificity for early detection.

Based on end user, the market is segmented into Hospitals, Blood Banks, Others. the blood banks segment holds the significant share of the blood screening market. Laboratory screening of donated blood and blood products for infectious diseases is a key safety measure to protect patients and to prevent the spread of serious infectious diseases.

For a better understanding of the market adoption of Automotive Catalytic Converter, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, Rest of North America), Europe (Germany, UK, France, Italy, Spain and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, Rest of APAC), and Rest of World.

Some of the major players operating in the market include Abbott Laboratories, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Becton, Dickinson And Company, Thermo Fisher Scientific Inc., bioMerieux, Inc., Grifols, S.A., Danaher Corporation, Boster Biological Technology, Demeditec Diagnostics GmbH, etc. Several M&A's along with partnerships have been undertaken by these players to boost their presence in different regions.

Scope of the Report

Products

Blood Screening Market is expected to grow at a CAGR of around 10% over the forecast period.

Companies

Abbott Laboratories, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Becton, Dickinson And Company, Thermo Fisher Scientific Inc., bioMerieux, Inc., Grifols, S.A., Danaher Corporation, Boster Biological Technology, Demeditec Diagnostics GmbH

Table of Contents

1 MARKET INTRODUCTION

1.1 Market Definitions

1.2 Limitation

1.3 Stake Holders

1.4 Currency used in Report

2 RESEARCH METHODOLOGY OR ASSUMPTION

2.1 Research Process of the Blood Screening Market

2.2 Research Methodology of the Blood Screening Market

2.3 Forecasting Method

2.4 Respondent Profile

2.5 Main Objective of the Blood Screening Market Study

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 BLOOD SCREENING MARKET COVID-19 IMPACT

6 BLOOD SCREENING MARKET REVENUE, 2019-2027F

7 MARKET INSIGHTS BY PRODUCT

7.1 Reagents & Kits

7.2 Instruments

7.3 Software & Services

8 MARKET INSIGHTS BY TECHNOLOGY

8.1 Nucleic Acid Amplification (NAAT)

8.1.1 Transcription Mediated Amplification (TMA)

8.1.2 Real Time Polymerase Chain Reaction (RT-PCR)

8.2 Enzyme Linked Immunosorbent Assay (ELISA)

8.2.1 Chemiluminescent Immunoassay (CLIA)

8.2.2 Fluorescent Immunoassays (FIA)

8.2.3 Colorimetric Immunoassays (CI)

8.3 Rapid Tests

8.4 Western Blotting

8.5 Next Generation Sequencing (NGS)

9 MARKET INSIGHTS BY END USER

9.1 Hospitals

9.2 Blood Banks

9.3 Others

10 MARKET INSIGHTS BY REGIONS

10.1 NORTH AMERICA BLOOD SCREENING MARKET

10.1.1 United States

10.1.2 Canada

10.1.3 Rest of North America

10.2 EUROPE BLOOD SCREENING MARKET

10.2.1 United Kingdom

10.2.2 Germany

10.2.3 France

10.2.4 Italy

10.2.5 Spain

10.2.6 Rest of Europe

10.3 ASIA-PACIFIC BLOOD SCREENING MARKET

10.3.1 China

10.3.2 Japan

10.3.3 India

10.3.4 Australia

10.3.5 Rest of Asia-Pacific

10.4 REST OF WORLD BLOOD SCREENING MARKET

11 BLOOD SCREENING MARKET DYNAMICS

11.1 Market Drivers

11.2 Market Challenges

11.3 Impact Analysis

12 BLOOD SCREENING MARKET OPPORTUNITIES

13 BLOOD SCREENING MARKET TRENDS

14 COMPETITIVE LANDSCAPE

14.1 Company Shares, By Key Players

15 COMPANY PROFILED

15.1 Abbott Laboratories

15.2 Bio-Rad Laboratories, Inc

15.3 F. Hoffmann-La Roche Ltd

15.4 Becton, Dickinson And Company

15.5 Thermo Fisher Scientific Inc

15.6 bioMerieux, Inc

15.7 Grifols, S.A.

15.8 Danaher Corporation

15.9 Boster Biological Technology

15.10 Demeditec Diagnostics GmbH

16 DISCLAIMER

Research Methodology

Why Buy From Us?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022